Avanafil Impurities | SZEB

Avanafil is a PDE5 inhibitor approved for erectile dysfunction by the FDA on April 27, 2012 and by EMA on June 21, 2013. 

To support your analysis and help ensure the accuracy of quality processes, we supply a range of Avanafil -related impurities standards with certified COA and characterization data like Mass, HPLC, NMR & TGA report.

The following are some of the impurities of Avanafil :